All In Biotech

Free tool

FAERS Monitor: Afrezza

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 022472 or its brand name (Afrezza, Insulin Recombinant Human). Reports on generic versions are filed under their own applications.

Reports

8,026

Serious

5,651

70% of reports

Hospitalization

3,162

Death reported

789

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased1,327
  • drug ineffective583
  • hypoglycaemia458
  • cough446
  • blood glucose decreased398
  • dyspnoea398
  • hyperglycaemia357
  • diarrhoea341
  • off label use319
  • headache283
  • nausea271
  • wrong technique in product usage process263
  • weight decreased257
  • fall250
  • fatigue249

Reports by year received

View as table
YearReports
200454
200554
200644
200773
200869
200967
201076
2011100
201296
2013160
2014369
20151,116
2016315
2017201
2018512
2019448
2020400
2021581
2022791
2023701
2024681
2025647
2026471

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,133 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hyperglycaemiaSignal35725.923.48,459
hypoglycaemiaSignal45825.022.810,440
blood glucose decreasedSignal39821.919.97,867
blood glucose increasedSignal1,32718.617.722,100
coughSignal4464.23.81,086
wrong technique in product usage processSignal2633.43.0448
weight decreasedSignal2572.42.1214
fall2502.01.7120
dyspnoea3981.81.7157
diarrhoea3411.41.237
headache2831.21.18
drug ineffective5831.21.113
off label use3191.00.91
nausea2710.90.83
fatigue2490.80.78

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.